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MPO (myeloperoxidase) catalyses the oxidation of chloride,
bromide and thiocyanate by hydrogen peroxide to HOCl
(hypochlorous acid), HOBr (hypobromous acid) and HOSCN
(hypothiocyanous acid) respectively. Speciﬁcity constants
indicatethatSCN
− isamajorsubstrateforMPO.HOSCNisalsoa
major oxidant generated by other peroxidases including salivary,
gastric and eosinophil peroxidases. While HOCl and HOBr are
powerful oxidizing agents, HOSCN is a less reactive, but more
speciﬁc, oxidant which targets thiols and especially low pKa
species.InthepresentstudyweshowthatHOSCNtargetscysteine
residues present in PTPs (protein tyrosine phosphatases) with this
resulting in a loss of PTP activity for the isolated enzyme, in cell
lysates and intact J774A.1 macrophage-like cells. Inhibition also
occurswithMPO-generatedHOClandHOBr,butismoremarked
with MPO-generated HOSCN, particularly at longer incubation
times. This inhibition is reversed by dithiothreitol, particularly
at early time points, consistent with the reversible oxidation of
the active site cysteine residue to give either a cysteine–SCN
adduct or a sulfenic acid. Inhibition of PTP activity is associated
with increased phosphorylation of p38a and ERK2 (extracellular-
signal-regulatedkinase2)asdetectedbyWesternblotanalysisand
phosphoprotein arrays, and results in altered MAPK (mitogen-
activated protein kinase) signalling. These data indicate that the
highly selective targeting of some protein thiols by HOSCN can
result in perturbation of cellular phosphorylation and altered
cell signalling. These changes occur with (patho)physiological
concentrations of SCN
− ions, and implicate HOSCN as an
important mediator of inﬂammation-induced oxidative damage,
particularlyinsmokerswhohaveelevatedplasmalevelsofSCN
−.
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INTRODUCTION
MPO (myeloperoxidase) is a highly basic haem enzyme that
is released extracellularly by activated neutrophils, monocytes
and some macrophages. MPO catalyses the oxidation of halide
(Cl
−,B r
−) and pseudohalide (thiocyanate ion, SCN
−) ions by
H2O2 (hydrogen peroxide) to the corresponding hypohalous
acids: HOCl (hypochlorous acid), HOBr (hypobromous acid) and
HOSCN (hypothiocyanous acid; cyanosulfenic acid) (reviewed
in [1–3]). These species exist as a mixture of their acid and
anion forms at physiological pH values (pKa 7.6, 8.7 and
approx. 5.3 respectively; reviewed in [1]); HOCl, HOBr and
HOSCN are used hereon to indicate the physiological mixtures
of these species. Cl
− is present at much higher concentrations
in plasma (100–140 mM) than other anions with which MPO
reacts (Br
−, 20–100 μM; SCN
−, 20–250 μM; [4,5]), but MPO
has a much greater speciﬁcity constant for SCN
− than for
Cl
− or Br
− (approx. 730- and 60-fold greater respectively;
[5]). This results in a signiﬁcant proportion of the H2O2
consumed by MPO being utilized to oxidize SCN
− at pH 7.4, and
HOSCN is a major oxidant generated by MPO in plasma [5,6].
Other peroxidases, including salivary-, gastric- and eosinophil-
peroxidase, also have high speciﬁcity constants for SCN
−,
resulting in signiﬁcant yields of HOSCN (reviewed in [1,6]). This
is of particular importance in saliva, stomach lining ﬂuid and the
airway lining ﬂuid, where SCN
− is concentrated [7,8]. Formation
of HOSCN may also be of particular signiﬁcance in smokers
who have markedly elevated plasma SCN
− concentrations [9].
HOClandHOBralsoreactrapidlywithSCN
−,therebyenhancing
the yield of HOSCN [10,11]. HOSCN is therefore a major
oxidant generated both directly by multiple peroxidases at sites
of inﬂammation, and as a result of secondary reactions [6].
HOCl and HOBr are powerful oxidants and important
components of the human immune response against invading
pathogens [2]. However, excessive or misplaced production
of these species can result in host tissue damage, with this
having been implicated in a wide range of human inﬂammatory
diseases, including cardiovascular disease, rheumatoid arthritis,
asthma, cystic ﬁbrosis, some cancers, certain neurodegenerative
conditions, kidney disease and inﬂammatory bowel disease
(reviewed in [1–3,12]).
In contrast with HOCl and HOBr which react rapidly
with multiple cellular and extracellular targets (reviewed in
[13]), HOSCN is highly selective, with the reaction occurring
predominantly with thiol (RSH) groups [14], with rate constants,
k,intherange10
4–10
6 M
−1 ·s
−1 [15,16].Reactionwithtryptophan
residues may also be signiﬁcant when thiol residues are absent or
depleted [17]. This selective targeting of thiols has been shown to
result in a more marked induction of apoptosis by HOSCN, than
equimolar concentrations of HOCl and HOBr, with some cells
([18]; reviewed in [6]).
Abbreviations used: DTT, dithiothreitol; ECL, enhanced chemiluminescence; ERK, extracellular-signal-regulated kinase; HOBr, hypobromous acid;
HOCl, hypochlorous acid; HOSCN, hypothiocyanous acid; HRP, horseradish peroxidase; LPO, lactoperoxidase; MAPK, mitogen-activated protein kinase;
MKK, MAPK kinase; MPO, myeloperoxidase; PTP, protein tyrosine phosphatase.
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The potential role of HOSCN in human disease is poorly
understood, but previous studies have provided evidence for a
role for SCN
−-derived species in models of atherosclerosis, and
humans with cardiovascular disease [9,19–21]. These data are of
particularrelevancetosmokerswhotypicallyhaveelevatedlevels
of SCN
− and an increased risk of multiple pathologies.
Phosphorylation of tyrosine, threonine and serine residues
plays a key role in the regulation of signal transduction in
mammalian cells, and hence control of cell activation, cell-
cycle progression, cytoskeletal rearrangement, cell movement,
differentiation, apoptosis and metabolic homoeostasis [22,23].
Phosphorylation is typically reversible and dynamic with the
extent governed by the opposing activities of large families of
proteintyrosinekinasesandPTPs(proteintyrosinephosphatases)
in the case of tyrosine phosphorylation [24]. Oxidants can
modulate signalling by both enzyme families, as both PTPs
and kinases are redox sensitive [25]. Oxidation of PTP cysteine
residues, and particularly the low pKa active site cysteine, occurs
with multiple oxidants including H2O2 [26], peroxynitrite [27],
singlet oxygen [28] and amino acid and protein peroxides [29],
with this resulting in enzyme inactivation. In contrast, oxidation
of kinases can result in activation, either by cysteine modiﬁcation
or other mechanisms [25,30]. Such perturbations have been
implicated in a number of diseases including cancer, diabetes,
rheumatoid arthritis and hypertension [22,24,25]. One member
of this family, PTP1B is an important enzyme in the negative
regulationoftheinsulinreceptorandatherapeutictargetinType2
diabetesandobesity[31].Theactivesitecysteineresidue[32]can
be reversibly oxidized to a sulfenyl-amide species, which causes
large changes in the PTP1B active site; this can be reversed by
the key cellular reducing agent glutathione, although it can also
undergo irreversible oxidation to higher oxy acids [31].
In light of the selectivity of HOSCN for thiol residues, and
particularly low pKa species [15], and evidence for the induction
of apoptosis by HOSCN [6,18], we hypothesized that PTPs
might be cellular targets of HOSCN, and that this might result
in altered cellular signalling. We demonstrate in the present
study that HOSCN inhibits isolated PTP1B, and PTP activity
in J774A.1 cells. The inhibition occurs at pathophysiological
concentrations of oxidant. This loss of activity is accompanied by
hyperphosphorylation of p38α and ERK2 [extracellular-signal-
regulated kinase 2; MAPK1 (mitogen-activated protein kinase
1)] and increased expression of transcription factors, suggesting
that HOSCN induces apoptosis via the MAPK pathway in
macrophages.
EXPERIMENTAL
Materials
Aqueous solutions and buffers were prepared using nanopure
water ﬁltered through a four-stage Milli-Q system (Millipore
Waters). LPO (lactoperoxidase; from bovine milk; Calbiochem)
was quantiﬁed by absorbance at 412 nm using a molar absorption
coefﬁcient of 112000M
−1 ·cm
−1 [33]. H2O2 [30% (v/v) solution;
Merck] was quantiﬁed at 240 nm using a molar absorption coef-
ﬁcient of 39.4 M
−1 ·cm
−1 [34]. Antibodies were obtained from
thefollowingsources:anti-human/mouse/ratERK1/ERK2mono-
clonal antibody, anti-phospho-ERK1 (Thr
202/Tyr
204)/ERK2
(Thr
185/Tyr
187) monoclonal antibody, anti-human/mouse/rat p38α
monoclonal antibody, anti-phospho-p38 MAPK afﬁnity-puriﬁed
antibody, anti-human/mouse/rat MKK (MAPK kinase) 3/MKK6
monoclonal antibody (all R&D Systems), anti-phospho-MKK3/6
monoclonal antibody (Cell Signalling Technology) and β-actin
antibody (Santa Cruz Biotechnology). Secondary antibodies
were: sheep anti-mouse Ig, peroxidase-conjugated (Chemicon,
Millipore) and ECL (enhanced chemiluminescence) rabbit IgG,
HRP (horseradish peroxidase)-linked whole antibody (from
donkey) (GE Healthcare).
Cell culture
Murine macrophage-like J774A.1 cells (A.T.C.C.) were cultured
under sterile conditions in DMEM (Dulbecco’s modiﬁed
Eagle’s medium; Sigma–Aldrich) supplemented with 10%
(v/v) heat-inactivated fetal bovine serum (Invitrogen), 2 mM
L-glutamine (Thermotrace), 100 units/ml penicillin and
0.1 mg/ml streptomycin (Invitrogen). Cells were seeded at
0.5×10
6 cells/ml in six-well plates. The medium was removed
and cells washed twice with PBS (Amresco) before treatment.
Protein concentrations were determined using the BCA
(bicinchoninic acid) assay (Pierce) using BSA standards (Sigma).
Preparation of HOSCN
HOSCN was prepared enzymatically by incubation of LPO (1.5–
2 mM) for 15 min with NaSCN (7.5 mM; Sigma) and H2O2
(3.75 mM added as 5×10 μl aliquots, 1 min apart) in 10 mM
potassiumphosphatebuffer(pH 6.6;Sigma)at22◦C.Thereaction
was stopped by the addition of catalase (140 i.u., bovine liver;
Sigma), with this enzyme and LPO subsequently removed by
centrifugation through a 10000 Da molecular-mass cut-off ﬁlter
(Pall Life Sciences) at 11200 g for 5 min. HOSCN was quantiﬁed
by reaction with TNB (5-thio-2-nitrobenzoic acid; Sigma), with
a molar absorption coefﬁcient of 14150 M
−1 ·cm
−1 at 412 nm
[17,18], and used immediately.
PTP activity assay
PTP activity was determined by quantifying the conversion of
p-nitrophenyl phosphate (Calbiochem) into the p-nitrophenolate
anion as described previously [29], with the latter quantiﬁed
by A405 and comparison with a p-nitrophenolate standard curve
(Sigma). PTP activity was determined after exposure of isolated
PTP1B(recombinant protein from Escherichia coli; Calbiochem)
orJ774A.1celllysates(0.33+ −0.03 mgofprotein/ml)toHOSCN,
enzyme reactions or control treatments for the times stated. For
the isolated PTP1B studies, DTT (dithiothreitol) present in the
commercial preparations was removed before use by washing
the enzyme with buffer using a 3000 Da molecular-mass cut-off
ﬁlter spun at 11200 g. The enzyme (0.5 μM, 18.7 μg·ml
−1)w a s
subsequentlyexposedtophosphatebufferorHOSCNfor5 minat
22◦C. Then, 10 ml of 2.5 mM cysteine (to quench the remaining
H O S C N )w a sa d d e dt o7 0μl aliquots of the reaction mixture
in a 96-well plate, then 10 μlo f4m Mp-nitrophenyl phosphate
was added and incubated for 60 min at 22◦C. The reaction was
subsequently stopped by the addition of 10 μl of 0.1 M KOH and
the absorbance at 405 nm was recorded.
Intact J774A.1 cells were exposed to HOSCN at the
concentrations indicated, in PBS, and incubated for the times
indicated at 22◦C. Any residual oxidant was removed by
aspiration of the cell supernatant, with the remaining cells
carefully scraped into PBS (0.5×10
6 cells/ml) and centrifuged
at 1000 g for 5 min. The cells were resuspended at 4×10
6
cells/ml, and treated with nanopure water and freeze–thawed on
dry ice to ensure lysis. The PTP assay was performed using
0.32+ −0.06 mg of protein/ml. Incubation of cell lysates with
MPO-generated oxidants was carried out by incubation of the
lysates(asabove)withMPO(100 nM)andH2O2 (25 μMaddedas
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5×2.8 μlaliquots,1 minapart)inthepresenceof100 μMCl
− or
100 μMBr
− orvariousconcentrationsofSCN
− atpH 7.4at22◦C
in 10 mM potassium phosphate buffer. MPO was removed after
reaction with p-nitrophenyl phosphate and prior to quantiﬁcation
of the p-nitrophenolate anion by centrifugation of the solution
through a 10000 Da molecular-mass cut-off ﬁlter (Pall Life
Sciences) at 11200 g for 5 min.
Quantiﬁcation of thiols
ThioGlo-1
TM (Calbiochem) was used for the ﬂuorometric
quantiﬁcation of thiols [35]. Stock solutions of ThioGlo
TM
(2.6 mM) in acetonitrile were prepared and stored at 4◦C.
Immediately prior to use, the stock was diluted 1:100 in PBS
(pH 7.5). Working reagent (50 μl) was added to 50 μlo ft h e
isolatedPTP1Bandincubatedfor5 minat22◦C.Thiolconcentra-
tions were quantiﬁed by ﬂuorescence spectroscopy with
λex =360 nm and λem =530 nm using GSH (Sigma–Aldrich)
to construct a standard curve. The absolute levels of thiols
detected on the isolated PTP1B was less than expected based
ontheproteincomposition(comparewithUniProtKB/Swiss-Prot
accession number P18031), indicating that some oxidation of the
enzyme had occurred during isolation/handling.
Phospho-MAPK antibody array
TheMAPKsignallingpathwaywasinvestigatedusingaProteome
Proﬁler
TM Human Phospho-MAPK Antibody Array following
the manufacturer’s protocol (R&D Systems). J774A.1 cells
(1×10
6) were exposed to 50 μM HOSCN for 15 min, then cell
proteins were extracted and the concentration determined (Lowry
assay, Bio-Rad). Total cell protein (300 μg) was hybridized to
the array membranes, the arrays were washed and incubated
with the detection antibody cocktail labelled with streptavidin–
HRP. Chemiluminescent detection was performed with ECL
(Amersham). Signals were directly digitized using a ChemiDoc
XRS (Bio-Rad).
Western blot analysis
Cells (1×10
6 cells/ml) were treated with HOSCN (15 min at
22◦C), total protein was extracted with RIPA buffer [50 mM
Tris/HCl (pH 8), 150 mM NaCl, 1% Nonidet P40, 0.1% SDS,
0.5%sodiumdeoxycholateand1:100dilutedproteinaseinhibitor
cocktail] and protein was quantiﬁed using the Lowry assay
(Bio-Rad). Protein (20–35 μg) was separated by SDS/PAGE
on 12% acrylamide gels, then transferred on to nitrocellulose
membranes (iBlot
TM, Invitrogen). The membrane was then
probed with either anti-ERK1/2 antibody(1:1000), anti-phospho-
ERK1/2 antibody (1:1000), anti-p38α antibody (1:1000), anti-
phospho-p38 antibody (1:2000), anti-MKK3/6 antibody (1:500)
or anti-phospho-MKK3/6 antibody (1:1000). After a wash step, a
secondary antibody was applied which was either peroxidase-
conjugated sheep anti-mouse Ig or donkey anti-rabbit IgG
(1:2000). The secondary antibodies were subsequently detected
by ECL as described above. Band densities were quantiﬁed using
Quantity One software (Bio-Rad) and normalized to the levels
of β-actin, the housekeeping control protein. β-Actin levels were
measured after stripping the membranes [200 mM glycine, 1%
(w/v) SDS and 1% (v/v) Tween 20 (pH 2.2)] and subsequent
re-probing with β-actin antibody (1:2000).
MAPK signalling pathway PCR array
Cells were treated with 0 (buffer) or 50 μM HOSCN for 15 min
at 22◦C, and then total RNA was extracted using the RNeasy Plus
Mini Kit (Qiagen). Each well was extracted individually and,
following isolation, two wells were pooled and concentrated to
half the original volume using a vacuum concentrator (Vacufuge
Concentrator 5301; Eppendorf). The SYBR-Green II RNA assay
(Molecular Probes, Invitrogen) was used to normalize all samples
to a concentration of 200 ng/ml. The integrity of the RNA
was veriﬁed using an Experion bioanalyser (Bio-Rad). The
mRNA within each sample was converted into cDNA using a
reverse transcription RT
2 First Strand Kit (SA Biosciences). The
resultantcDNAwasassayedbyPCRampliﬁcationusingaMAPK
Signalling Pathway PCR Array kit (SA Biosciences) based on the
RT
2 SYBR green/Fluorescein PCR master mix (SA Biosciences).
PCR ampliﬁcation was performed using an iCycler (Bio-Rad).
AnalysisofgeneexpressionwascompletedusingSABiosciences
PCR Array Data Analysis Web Portal, as recommended by the
manufacturers, and veriﬁed using the   Ct method.
Statistical analyses
StatisticalanalysiswasperformedusingGraphPadPrismsoftware
4.0(GraphPadSoftware,http://www.graphpad.com)usingone-or
two-way ANOVA with Bonferroni’s or Tukey’s post-hoc test (as
indicated) with P<0.05 taken as statistically signiﬁcant.
RESULTS
Inhibition of isolated PTP1B activity by HOSCN
Isolated PTP1B (0.5 μM) was incubated with 0–25 μM HOSCN
(generated enzymatically using a LPO/H2O2/SCN
− system; see
the Experimental section) for 5 min at 22◦C (pH 7.4), before
assessmentoftheremainingenzymeactivityusingtheconversion
of p-nitrophenyl phosphate into p-nitrophenolate anion, with
the latter quantiﬁed spectrophotometrically at 405 nm. Exposure
to HOSCN resulted in a signiﬁcant concentration-dependent
decreaseinactivityrelativetocontrolsamplesatconcentrationsof
HOSCN12.5 μM(i.e.25-foldmolarexcessofoxidantrelative
to protein; Figure 1A). The loss of activity was time-dependent,
with 5 μM HOSCN (10-fold molar excess of oxidant) inducing
∼90% inhibition by 120 min (results not shown). A slow loss
of activity was also detected in control incubations with buffer
alone over extended incubation times, presumably due to thiol
autoxidation (∼37% inhibition by 120 min; results not shown).
The role of cysteine modiﬁcation in this inhibition was
examined by quantifying protein thiol levels in identical
incubations using ThioGlo-1
TM, which reacts with free thiols
to give ﬂuorescent adducts. Treatment of PTP1B with oxidant
resulted in a signiﬁcant decrease in protein thiol concentration,
with this being signiﬁcant at 2.5 μM HOSCN (i.e. >5-fold
molar excess of oxidant to protein; Figure 1B). No signiﬁcant
background ﬂuorescence was detected in control experiments
performed in the absence of PTP1B indicating that HOSCN does
not react directly with ThioGlo-1
TM.
Inhibition of PTP activity in cell lysates and intact cells by HOSCN
Incubation of J774A.1 cell lysates with 0–200 μM HOSCN for
5 min resulted in a concentration-dependent loss of PTP activity.
This loss of activity was statistically signiﬁcant with 10 μM
HOSCN when compared with controls treated with phosphate
bufferalone(Figure2A).Thislossofactivitywastime-dependent,
c   The Authors Journal compilation c   2010 Biochemical Society164 A. E. Lane and others
Figure 1 Inhibition of isolated PTP1B activity and loss of cysteine residues
on treatment with HOSCN
IsolatedPTP1Bwaswashedwithbufferusinga3000Damolecularmasscut-offﬁltertoremove
DTT present in the commercial preparation before use. The protein (0.5μM, 18.7μg·ml−1)
was subsequently exposed to HOSCN at the concentrations indicated for 5min at 22◦C
before determination of residual enzymatic activity and remaining thiols. (A) PTP activity
(0.090μM, 3.3 μg·ml−1 PTP1B ﬁnal assay concentration). (B) Thiol groups present in
isolated PTP1B (0.25μM, 9.35μg·ml−1 PTP1B ﬁnal assay concentration) were measured
using ThioGlo-1TM with GSH used to construct a standard curve. Values are means+ −S.E.M.
of duplicate determinations from three separate experiments. Statistical analyses compared
all concentrations with the 0μM HOSCN condition using one-way ANOVA with Bonferroni’s
post-hoc test; *P <0.05.
with a signiﬁcantly greater loss of activity detected at 15 min
compared with 5 min with 25 μM HOSCN. At longer time
points (up to 2 h), no further decrease in activity was detected
(Figure 2B). No loss of activity was measured in controls treated
with phosphate buffer alone over the same time period.
The potential reversibility of inactivation was examined in
lysates treated with 25 μM HOSCN for either 15 or 120 min,
with subsequent further incubation with 10 mM DTT for 10 min.
For the samples treated with HOSCN for 15 min, DTT treatment
induced a partial recovery of activity; however, for those samples
exposed to HOSCN for 120 min, the recovery of activity was
signiﬁcantlyless(Figure3).Theseresultssuggestthatthedamage
inducedbyHOSCNis(atleastpartially)reversibleovershorttime
periods, but over longer time periods becomes irreversible.
Treatment of intact J774A.1 cells (5×10
5) with 10–250 μM
HOSCN for 60 min in PBS also resulted in a loss of PTP
activity, with this becoming signiﬁcant at oxidant concentrations
100 μMHOSCN(Figure4).Withthisconcentrationofoxidant,
signiﬁcant differences in activity were detected between the
control and treated samples at all non-zero time points examined
(15, 30 and 60 min; results not shown).
Figure 2 Inhibition of PTP activity in J774A.1 cell lysates by HOSCN
PTP activity in cell lysates (0.33+ −0.03mg of cell protein/ml) was determined after incubation
with: (A) HOSCN at the concentrations indicated for 5 min; (B) phosphate buffer ()o r2 5μM
HOSCN () for the times indicated. Values are means+ −S.D. of triplicate determinations from
each of four separate experiments. Statistical analyses in (A) compared all concentrations
with the 0 μM oxidant condition using one-way ANOVA with Bonferroni’s post-hoc test; in
(B) analyses compared the control with HOSCN-treatment at each time point using two-way
ANOVA with Bonferroni’s post-hoc test. In both cases * indicates P <0.05.
Figure 3 Inhibition of PTP activity in J774A.1 cell lysates by HOSCN is
reversible with short exposure times, but irreversible on prolonged oxidant
treatment
PTP activity in cell lysates (0.33+ −0.03mg of cell protein/ml) was determined after incubation
with phosphate buffer or 25μM HOSCN for 15min (solid bars) and 120min (open bars) at
22◦Cfollowedbytreatmentwith10mMDTTfor10 minat37◦C.Valuesaremeans+ −S.E.M.of
triplicatedeterminationsfromeachoffourseparateexperiments.Statisticalanalyseswerecarried
out using two-way ANOVA with Bonferroni’s post-hoc test, *P <0.05. NS, not signiﬁcantly
different.
Inhibition of PTP activity in cell lysates by MPO-generated oxidants
The above studies were subsequently extended to determine
whether oxidants generated by a MPO/H2O2/SCN
− system
behaved in the same manner to pre-formed HOSCN, and how
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Figure 4 Inhibition of PTP activity in intact J774A.1 cells by HOSCN
PTP activity (expressed per mg of cell protein) in cells (plated at 0.5×106 cells/ml with
assay performed at 0.32+ −0.06mg of cell protein/ml) was determined after incubation with
HOSCN, at the concentrations indicated, for either 15min (solid bars) or 60min (open bars)
at 22◦C. Values are means+ −S.E.M. of duplicate determinations from each of two wells from
three separate experiments. Statistical analyses compared all concentrations with the 0μM
oxidant conditions using one-way ANOVA with Bonferroni’s post-hoc test; *P <0.05. ND, not
determined.
Figure5 Concentration-dependentinhibitionofPTPactivityinJ774A.1cell
lysates by MPO-derived oxidants
PTP activity in cell lysates (0.33+ −0.03mg of cell protein/ml) was determined after incubation
with 100nM MPO and 100mM Cl− (open bars), 100μMB r − (solid bars) or 100μMS C N −
(greybars)with25μMH 2O2 forthetimesindicatedat22◦C.Afterincubationthesampleswere
ﬁltered using 10000 Da molecular mass cut-off ﬁlters to remove MPO before quantiﬁcation of
the p-nitrophenolate anion released from the p-nitrophenylphosphate. Controls were incubated
in the absence of H2O2. Values aremeans+ −S.D. of triplicate determinations from each of three
separate experiments. Statistical analyses were carried using two-way ANOVA with Bonferroni’s
post-hoctest.*P <0.05foreachofthedatasetsateachtimepointcomparedwiththetimezero
control.#P <0.05forthe100μMSCN − conditioncomparedwiththeCl− andBr− conditions
at the same time point. †P <0.05 for the 60min compared with 15min time points for the
100μMS C N − condition.
damage induced by SCN
−-derived oxidants might differ from
those generated from Cl
− and Br
− at pathophysiological levels.
Incubation of cell lysates (as above) with MPO (100 nM) and
H2O2 (25 μM, added as ﬁve separate aliquots over 5 min) at
pH 7.4 in the presence of 100 μMS C N
− resulted in a signiﬁcant
loss of PTP activity after 15 min incubation, with a further loss of
activitydetectedat30and60 min,indicatingthatinhibitionoccurs
in a time-dependent manner (Figure 5). Similar experiments in
which 100 mM Cl
− or 100 μMB r
− were used in place of SCN
−,
resulted in a loss of PTP activity after 15 min, but no further loss
of activity at longer incubation times (Figure 5). At each of the
non-zerotimepointstheextentofinhibitioninducedbytheSCN
−
system was signiﬁcantly greater than that observed with the Cl
−
Figure6 Concentration-dependentinhibitionofPTPactivityinJ774A.1cell
lysates by MPO-derived HOCl and HOSCN
PTP activity in cell lysates (0.33+ −0.03mg of cell protein/ml) was determined after incubation
with 100nM MPO, 100mM Cl− and increasing concentrations of SCN− with 25μMH 2O2 for
15min at 22◦C. Control samples contained cell lysates, MPO and H2O2 incubated under the
same conditions, but in the absence of any added Cl− or SCN−. After incubation MPO was
removedbeforequantiﬁcationofthereleasedp-nitrophenolateanionasdescribedinthelegend
to Figure 5. Values are means+ −S.D. of four determinations from two separate experiments.
Statisticalanalyseswerecarriedoutusingarepeatedmeasuresone-wayANOVAwithBonferroni’s
post-hoc test. *P <0.05 for the absence of both Cl− and SCN− compared with the presence
of 100mM Cl−.# P <0.05 for increasing concentrations of SCN− in the presence of 100mM
Cl− compared with the absence of SCN−.
or Br
− systems. The extent of inhibition induced by the latter
two systems was not signiﬁcantly different. These results indicate
that PTPs are rapidly inactivated by each of the MPO/H2O2/Cl
−,
MPO/H2O2/Br
− and MPO/H2O2/SCN
− systems. However, the
MPO/H2O2/SCN
− system induces both a time-dependent loss of
activity, and a greater overall extent of inhibition with identical
oxidant concentrations.
Subsequent experiments examined the effect of different SCN
−
concentrations in the presence of 100 mM Cl
−. Increasing
SCN
− concentrations (50–300 μM) in the MPO/H2O2/Cl
−/SCN
−
system induced greater inhibition at 15 min than MPO/H2O2/Cl
−
alone (Figure 6). These results indicate that the presence and
concentration of SCN
− is a key determinant of the extent of PTP
inhibition with the complete MPO/H2O2/halide/pseudohalide ion
systems.
Treatment of J774A.1 cells with HOSCN promotes MAPK protein
phosphorylation
As decreased PTP activity may alter the balance between
phosphorylated and non-phosphorylated proteins within cells,
the extent of protein phosphorylation in native and HOSCN-
treated cells was examined, using both phospho-protein arrays
and Western blotting. As a previous study has demonstrated
that HOSCN reacts with J774A.1 cells (i.e. is consumed) and
inducesmarkedapoptosis[18],activationoftheMAPKsignalling
pathway was examined in detail.
Levels of phosphorylated MAPK proteins in J774A.1 cells
(1×10
6 cells)treatedwitheitherPBS(control)or50 μMHOSCN
in PBS (pH 7.4) for 15 min at 37◦C were detected using a
Proteome Proﬁler
TM Human Phospho-MAPK Antibody Array.
Oxidant exposure resulted in signiﬁcant increases in the levels of
phosphorylated p38α and ERK2 (MAPK1) (Figure 7A).
ThesestudieswereextendedbytreatingJ774A.1cells(1×10
6)
with 0–250 μM HOSCN for 15 min before protein extraction
and Western blot analysis of total and phosphorylated forms of
p38a, MKK3/6 and ERK1/2. Signiﬁcant increases in the level
of phosphorylated p38α were detected with increasing oxidant
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Figure 7 Effect of HOSCN on the extent of protein phosphorylation in J774A.1 cells
(A) MAPK array for phosphorylated proteins detected in J774A.1 cells (1×106) treated with either (a) PBS or (b) 50μM HOSCN in PBS, pH7.4, for 15min at 37◦C. After oxidant (or control)
exposure, cells were lysed using the buffer provided with the kit, and 300μg of protein (determined using the Bio-Rad protein assay) used for each array. Following binding, the arrays were washed
and reacted with the supplied antibody cocktail as speciﬁed by the manufacturer. Chemiluminescent detection was performed with ECL with the signals detected using a Bio-Rad ChemiDoc XRS
system and Bio-Rad Quantity One software (version 4.6.1). Pairs of protein spots marked ‘1’ are positive controls. Duplicate spots from phosphorylated ERK2 (MAPK1; spots marked ‘2’) and p38α
(spotsmarked‘3’)areindicated.(B)Westernblotsoftotalandphosphorylatedp38α,andcorrespondinggeldensitometry(ratioofphosphorylatedtototal,n=3independentexperiments),fromcells
exposed to HOSCN at the stated concentrations as described for (A). (C) Western blots of total and phosphorylated MKK3 (solid bars) and MKK6 (open bars), and corresponding gel densitometry
(ratio of phosphorylated to total, from three independent experiments), from cells exposed to HOSCN at the stated concentrations as described for (A). (D) Western blots of total and phosphorylated
ERK1 (solid bars) and ERK2 (open bars), and corresponding gel densitometry (ratio of phosphorylated to total, from three independent experiments), from cells exposed to HOSCN at the stated
concentrations as described for (A). Statistical analyses compared the HOSCN-treated samples with the untreated control (PBS-treated) cells using one-way ANOVA with Bonferroni’s post-hoc test,
*P <0.05.
exposure, with no concomitant change in total p38α levels
(Figure 7B). Thus the ratio of phosphorylated to total p38α
protein was signiﬁcantly increased with a HOSCN concentration
of 250 μM. As p38α phosphorylation is regulated by activated
MKK3/6, phosphorylation of this protein complex was also
examined. Figure 7(C) shows that there was a dose-dependent
increase in phosphorylated MKK3/6 with this being statistically
signiﬁcant at oxidant concentrations 100 μM. Analogous
experiments with ERK2 antibodies (native and phosphorylated)
did not give rise to a statistically signiﬁcant increase in the extent
of phosphorylation (Figure 7D). The reasons for the discrepancy
between these data and those from the Proteome Proﬁler array
(Figure 7A) are unclear.
Levels of the upstream signalling molecules MKK3 and
MKK6, their phosphorylated counterparts, and the ratio of these
two forms were examined in a similar manner. Both MKK3
and MKK6 showed a dose-dependent increase in the ratio
of phosphorylated/non-phosphorylated protein with increasing
HOSCN concentrations, with this being signiﬁcant at 250
and 100 μM HOSCN for MKK3 and MKK6 respectively
(Figure 7C).
Activation of the MAPK pathway
The HOSCN-induced increase in MKK3/6 and p38α
phosphorylation suggests that this oxidant is activating MAPK
signalling. An expected downstream consequence of such
activation would be altered transcription of target genes. To test if
HOSCN induced differential expression of target genes, J774A.1
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Figure 8 Effect of HOSCN exposure on gene expression in J774A.1 cells
MAPK gene array following treatment of J774A.1 cells with HOSCN. Cells (plated at 0.5×106 ml−1) were exposed to 50μM HOSCN (open bars) or 100μM HOSCN (solid bars) in PBS at 37◦C
for 15min. Total RNA was subsequently extracted, used to synthesize cDNA and used in the MAPK signalling pathway PCR array as described in the Experimental section. Histograms show data for:
(A) transcription factors, (B) cyclin-related proteins, (C) MAPKs and (D) other genes. All genes were normalized against ﬁve reference genes and data are expressed relative to control (PBS-treated)
cells, and are means+ −S.E.M. for triplicate determinations from three independent experiments. Statistical analyses compared the HOSCN-treated samples with the no-oxidant (PBS-treated) control
cells using one-way ANOVA with Bonferroni’s post-hoc test, *P <0.05.
cells were exposed to 50 or 100 μM HOSCN, then mRNA levels
of 84 well-characterized genes associated with MAPK signalling
were assayed using a MAPK-speciﬁc PCR array. Results show
that the mRNA levels of 23 of the 84 genes were signiﬁcantly
altered by HOSCN treatment (Figure 8). These mRNAs encode
transcription factors, cyclin-related proteins and MAPK proteins.
These changes in mRNA levels conﬁrm that cellular exposure to
HOSCN affects the MAPK signalling pathway.
DISCUSSION
MPO, released by activated neutrophils, monocytes and some
macrophages, catalyses the oxidation of Cl
−,B r
− and SCN
−
by H2O2, to HOCl, HOBr and HOSCN respectively (reviewed
in [1–3]). These oxidants generated by both MPO [5], and
other peroxidases (including salivary, gastric and eosinophil
peroxidases; [1]) are important in the innate immune response
against invading pathogens [2,3], but have been implicated as
damaging agents in multiple human inﬂammatory pathologies
(reviewed in [1–3]). As HOSCN reacts selectively with thiols
(both low-molecular-mass and protein-bound [14,15,36]), it was
postulated that this oxidant might interfere with cell survival and
signalling processes dependent on PTPs, as these enzymes have
a conserved, low pKa, active site cysteine residue.
The results reported in the present paper indicate that both
pre-formed HOSCN and a MPO/H2O2/SCN
− system can inhibit
PTP activity of isolated PTP1B (with concomitant modiﬁcation
of cysteine residues on this protein), in cell lysates, and intact
J774A.1 macrophage-like cells. The HOSCN concentrations that
induce inhibition are within the concentration ranges believed
to be present at sites of inﬂammation (compared with hundreds
of micromolar generated by stimulated neutrophils at the
concentration present in blood [3], and millimolar concentrations
within the neutrophil phagosome [37]). The levels of SCN
−
required to form these concentrations of HOSCN are within those
detected in plasma, especially in heavy smokers [9].
PTP inhibition was also detected with MPO/H2O2/halide ion
systems using typical plasma concentrations of Cl
− (to generate
HOCl) and Br
− (to give HOBr) [4], indicating that these oxidants
can also modulate PTP activity. Both HOCl and HOBr react
more rapidly than HOSCN with cysteine residues (and other
species[13,15]),butarelessselectiveintheirreactions,consistent
with the rapid loss of PTP activity, and the slower, but greater,
extent of inhibition seen with HOSCN (compared with HOCl
and HOBr) at longer time points. This is ascribed to a rapid
and indiscriminate consumption of the HOCl or HOBr by other
cellular targets, compared with a slower, but more selective,
oxidation of cysteine residues by HOSCN. Cysteine oxidation
by HOSCN, although slower than with HOCl and HOBr (k for
both oxidants approx. 3×10
7 M
−1 ·s
−1 [38,39]; compared with
8×10
4 M
−1 ·s
−1 for HOSCN [15]), is much more rapid than for
H2O2 (see below) and peroxynitrite (approx. 9×10
3 M
−1 ·s
−1
[40]).
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InhibitionofisolatedPTP1Boccurredwithmuchloweroxidant
concentrations than the loss of PTP activity in cell lysates and
intact cells, with this ascribed to the presence of alternative
reactive targets in the lysate and intact cell systems. Thus in
these more complex systems there are multiple PTP isoforms
(the human genome encodes >100 PTPs [22,23]) that will
contributetotheoverallactivitydetected.Theobservedinhibition
curves are therefore likely to be composites of the effects on
multiple different enzymes, each of which may have a different
susceptibility tooxidation.Thepatternofinhibition detectedwith
both the lysates and intact cells is consistent with populations that
are both highly sensitive to oxidation (as indicated by the rapid
partial loss of overall PTP activity with low concentrations of
oxidant in Figure 2), and much more resistant (as indicated by the
signiﬁcant non-zero activity at very high oxidant concentrations;
Figure 2). This differential susceptibility to oxidation may also
rationalize the different oxidant concentrations required to induce
changes in the extent of protein phosphorylation detected with
p38a compared with MKK3/6.
The PTP inhibition observed in cell lysates could be reversed
by DTT at short incubation times. These results are consistent
with the initial reaction of the HOSCN with cysteine residues to
give a cysteine–SCN adduct (see [17,41]). These adducts can be
readilyreducedbyDTT,regeneratingthefreethiol.Thecysteine–
SCNadductmayalsoundergosubsequentslowhydrolysistogive
a sulfenic acid (RSOH) [42,43], an intermediate known to be
important in redox signalling and which is also reducible by DTT
[44], or further oxidation to give sulﬁnic (RSO2H) or sulfonic
(RSO3H) acids (as seen with peroxiredoxins [45]). Sulﬁnic and
sulfonic acids do not appear to be rapidly repaired within cells
[44].
This reversible PTP inhibition at early time points indicates
that oxidation of protein cysteine residues by HOSCN may serve
as a signalling phenomenon. Previous studies have reported that
PTPs can be speciﬁcally and reversibly inhibited by H2O2,a n d
this modulates cell signalling [22,46]. Although this effect is
well established, rate constants, k, for the reaction of H2O2
with the active site cysteine residues of PTPs have not been
determined. Data in the literature indicate that k for the reaction
of H2O2 with protein cysteine residues varies markedly (from
a value of 3 M
−1 ·s
−1 for Cys
34 on human serum albumin [47]
to approx. 10
7 M
−1 ·s
−1 for peroxiredoxins [48]). Owing to the
low concentrations of puriﬁed enzyme available, kinetic data
are not available for the reaction of HOSCN with PTPs, but
it has been reported that this oxidant reacts with other protein
cysteine residues, including the Cys
34 residue on BSA, with rate
constants in the range 1–7×10
4 M
−1 ·s
−1 [15]; these reactions
are therefore likely to be much more rapid than the corresponding
reactions for H2O2. The higher rates of reaction of HOSCN
over H2O2, and the absence of any known detoxifying agent for
this oxidant (unlike the situation with H2O2, which is rapidly
removed by glutathione peroxidases, peroxiredoxins and catalase
[49]), suggests that HOSCN may play an important role in
modulating cell signalling as a result of its much greater rate
of reaction, and hence potentially greater and more rapid effect at
lowconcentrations.However,itshouldbenotedthatHOSCNalso
reacts much more rapidly with the important cellular antioxidant
GSH, which will be a competing target within cells, than H2O2
(k 2.5–8×10
4 M
−1 ·s
−1 [15,16] compared with 0.87 M
−1 ·s
−1 for
HOSCNandH2O2 respectivelyatpH 7.4[50]),sothesigniﬁcance
of the greater reactivity of HOSCN is less clear.
The results of the present study indicate that a major functional
consequence of PTP inhibition is hyperphosphorylation of some
important cellular signalling proteins, thereby providing a novel
mechanism by which MPO-derived HOSCN can modulate cell
signalling and survival events. This inhibition of PTP activity has
potential major ramiﬁcations for signalling pathways {e.g. those
involving NF-κB (nuclear factor κB); [24]} dependent on these
events, and provides a direct link between thiol oxidation and
signalling events involving protein phosphorylation. Increased
phosphorylation of p38α, MKK3/6 and (to a lesser extent)
ERK1/2 has been detected in cells exposed to HOSCN, with
this associated with altered expression of multiple MAPK
target genes (including Map2k5, Map2k7, Map3k4, Mapk14 and
Mapk8ip3), the transcription factors CREB1 (cAMP-response-
element-binding protein 1) and Jun, and a number of cyclin-
related proteins. This differential gene expression proﬁle is
consistent with an associated activated stress response in the
oxidant-exposed cells, culminating in arrest of cell division and
induction of apoptosis. In previous studies we have shown that
HOSCN induces apoptosis, and to a lesser extent, necrosis [18].
In conclusion, HOSCN formation inhibits PTP activity that
in turn affects MAPK signalling. These effects are detected
with oxidant levels within the range expected at sites of
inﬂammation, implicating HOSCN-mediated thiol oxidation as
an important mediator of inﬂammation-induced modulation of
cellular signalling and oxidative damage. These events may
be of signiﬁcance in both smokers and non-smokers. Smokers
have elevated levels of plasma SCN
− that is the precursor of
HOSCN, whereas non-smokers can have signiﬁcant SCN
−levels
as a result of biogenesis from alkaloid and cyanogenic materials.
Ourﬁndingsareconsistentwith elevatedSCN
− cont r i b ut i ngt oan
enhanced risk of developing pathologies associated with multiple
inﬂammatory diseases.
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